Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05800483 · ClinicalTrials.gov registry record · NA

Improving Decision-Making for Low Health Literate Prostate CA Patients

A NA study, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
327
Enrollment target

NCT05800483: Completed NA study, sponsored by Northwell Health.

NCT05800483 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 327 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05800483, a NA study, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
327 participants
Enrollment target

Study Summary

This study used a randomized controlled trial to evaluate whether Healium (designed to target preference elicitation) is as efficacious as Healing Choices (a comprehensive education and decision tool) in improving outcomes for decision-making and emotional quality of life.

Primary Outcome

Decisional Conflict was measured with the Decisional Conflict Scale (DCS), a well-validated scale consisting of 16 items that assess four dimensions: informed, clarity, uncertainty, and support. The response ranges are on a 5-point Likert scale ranging from strongly agree to strongly disagree. To come up with a total score, the 16 items are summed, divided by 16 and multiplied by 25. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).

Interventions

  • BEHAVIORAL Healium

Trial Details

FieldValue
Enrollment Target 327 participants
Start Date 2020-03-01
Est. Completion 2022-12-31
Phase NA
Northwell Health

370 total trials

What the finished NCT05800483 record still lists

NCT05800483 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 1 intervention - of which Healium is the first listed.

NCT05800483 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05800483 about?

NCT05800483 is a clinical study titled "Improving Decision-Making for Low Health Literate Prostate CA Patients". This study used a randomized controlled trial to evaluate whether Healium (designed to target preference elicitation) is as efficacious as Healing Choices (a comprehensive education and decision tool) in improving outcomes for decision-making and emotional quality of life.

What is the current status of trial NCT05800483?

This trial is currently completed. It is a NA study. The enrollment target is 327 participants. The study started on 2020-03-01. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT05800483?

The interventions under investigation include: Healium (BEHAVIORAL).

Who is sponsoring clinical trial NCT05800483?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05800483's enrollment target sits among peer trials

327 309th of 2000 higher than 1,691 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486378 · 327 participants · Phase 2

    A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

  • NCT06370182 · 327 participants · NA

    Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05800483, the US trial registry maintained by the National Library of Medicine. NCT05800483 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.